icd_code stringlengths 3 7 | icd_version int64 9 10 | long_title stringlengths 7 163 |
|---|---|---|
XW23376 | 10 | Transfusion of Lisocabtagene Maraleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 6 |
XW24346 | 10 | Transfusion of Brexucabtagene Autoleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 6 |
XW24376 | 10 | Transfusion of Lisocabtagene Maraleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 6 |
XWH | 10 | New Technology, Anatomical Regions, Insertion |
XWHD7Q7 | 10 | Insertion of Neurostimulator Lead into Mouth and Pharynx, Via Natural or Artificial Opening, New Technology Group 7 |
XXE | 10 | New Technology, Physiological Systems, Measurement |
XXE0X07 | 10 | Measurement of Intracranial Vascular Activity, Computer-aided Assessment, New Technology Group 7 |
XXE0X48 | 10 | Measurement of Brain Electrical Activity, Computer-aided Semiologic Analysis, New Technology Group 8 |
XXE3X27 | 10 | Measurement of Pulmonary Artery Flow, Computer-aided Triage and Notification, New Technology Group 7 |
XXE3X58 | 10 | Measurement of Coronary Artery Flow, Quantitative Flow Ratio Analysis, New Technology Group 8 |
XXE3X68 | 10 | Measurement of Coronary Artery Flow, Computer-aided Valve Modeling and Notification, New Technology Group 8 |
XXE5X38 | 10 | Measurement of Infection, Whole Blood Reverse Transcription and Quantitative Real-time Polymerase Chain Reaction, New Technology Group 8 |
XXE5XM5 | 10 | Measurement of Infection, Whole Blood Nucleic Acid-base Microbial Detection, New Technology Group 5 |
XXE5XN6 | 10 | Measurement of Infection, Positive Blood Culture Fluorescence Hybridization for Organism Identification, Concentration and Susceptibility, New Technology Group 6 |
XXE5XR7 | 10 | Measurement of Infection, Mechanical Initial Specimen Diversion Technique Using Active Negative Pressure, New Technology Group 7 |
XXE5XT7 | 10 | Measurement of Intracranial Arterial Flow, Whole Blood mRNA, New Technology Group 7 |
XXE5XV7 | 10 | Measurement of Infection, Serum/Plasma Nanoparticle Fluorescence SARS-CoV-2 Antibody Detection, New Technology Group 7 |
XXE97U7 | 10 | Measurement of Infection, Nasopharyngeal Fluid SARS-CoV-2 Polymerase Chain Reaction, New Technology Group 7 |
XXEBXQ6 | 10 | Measurement of Infection, Lower Respiratory Fluid Nucleic Acid-base Microbial Detection, New Technology Group 6 |
XY0 | 10 | New Technology, Extracorporeal, Introduction |
XY0VX83 | 10 | Extracorporeal Introduction of Endothelial Damage Inhibitor to Vein Graft, New Technology Group 3 |
XY0YX28 | 10 | Extracorporeal Introduction of Taurolidine Anti-infective and Heparin Anticoagulant, New Technology Group 8 |
XY0YX37 | 10 | Extracorporeal Introduction of Nafamostat Anticoagulant, New Technology Group 7 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.